Skip to content

COSMEX

Active
Private limited companyfounded 2021active for 5 yearsRue François Englert 10, 1480 Tubize, BelgiumKBO/BCE: BE 0765.522.317
Summary

The computed 12-month bankruptcy probability of COSMEX is 5.2% (elevated). The 2024 annual accounts show equity of €403,524 and a net result of €5,386. Equity is growing by about 11% per year across the filed financial years. Its solvency ranks better than 12% of 6,065 sector peers (NACE 46, financial year 2024). The company has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals.

Overview

Activity
Wholesale of pharmaceutical and medical goods
NACE 46460Retail sale of pharmaceutical products NACE 47730
5 sites
Size
€5.2mtotal assets 2024
Staff
12.7 FTE
Equity
€403,524
Profit
€5,386
Financial health
36 Weak Checked score 2024
Bankruptcy probabilitywithin 12 months
5.2%
Structure
Parent
INTERCONCEPT · 51%
Holdings
1
Accounts 84 days overdue3 of 5 deeds read
Why 36raises riskFigures for financial year 2024 (filed 29-08-2025)Liquidity: current ratio 0.97, cash €316,7185 establishment units1 financial year not filed after the legal deadline; latest accounts 29 days lateShow the evidence

Checked score

Score 2024
36 / 100
Weak
Probability in this band: 4.2% to 15.0%
Financially better than 30% of its sector peers (NACE 46, small)
Financial strength · tick = 2023
Weak
Solvency 33-2
equity 7.8% of total assets
Liquidity 12-14
short-term debt 82.7% · cash 6.1%
Profitability 69=
return on assets 0.1%
Bankruptcy probability, 12 months
5.2% Elevated
0%0.5%1.5%4%10%≥ 25%

About 5 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.2% (4,375 companies, NACE 46, small)
Last 24 months 11-2024: 2.0% 12-2024: 1.8%▼ -0.2 percentage points vs 11-2024 01-2025: 1.8%● unchanged vs 12-2024 02-2025: 1.8%● unchanged vs 01-2025 03-2025: 1.7%▼ -0.1 percentage points vs 02-2025lowest value 04-2025: 2.2%▲ +0.5 percentage points vs 03-2025 05-2025: 2.7%▲ +0.5 percentage points vs 04-2025 06-2025: 2.9%▲ +0.2 percentage points vs 05-2025 07-2025: 3.2%▲ +0.3 percentage points vs 06-2025 08-2025: 4.0%▲ +0.8 percentage points vs 07-2025 09-2025: 2.6%▼ -1.4 percentage points vs 08-2025 10-2025: 2.6%● unchanged vs 09-2025 11-2025: 2.6%● unchanged vs 10-2025 12-2025: 2.6%● unchanged vs 11-2025 01-2026: 2.6%● unchanged vs 12-2025 02-2026: 2.6%● unchanged vs 01-2026 03-2026: 2.6%● unchanged vs 02-2026 04-2026: 2.9%▲ +0.3 percentage points vs 03-2026 05-2026: 3.5%▲ +0.6 percentage points vs 04-2026 06-2026: 3.8%▲ +0.3 percentage points vs 05-2026 07-2026: 2.0%▼ -1.8 percentage points vs 06-2026 08-2026: 2.9%▲ +0.9 percentage points vs 07-2026 09-2026: 3.3%▲ +0.4 percentage points vs 08-2026 10-2026: 5.2%▲ +1.9 percentage points vs 09-2026highest value
Credit of up to €14,000 on 30-day terms, only on tighter conditions: elevated estimated bankruptcy probability calls for adjusted credit terms
Liquidity insufficient (current ratio 0.97, compared with 1.08 in 2023, below 1; short-term debt: 82.7% and cash: 6.1% of total assets), and 92.2% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, small): better than 10% on solvency, 10% on liquidity, 58% on profitability and 41% on growth.

The bankruptcy probability was computed on 22-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Seven signals.
raises riskneutral
raises risk · Figures for financial year 2024 (filed 29-08-2025)
NBB · annual accounts
raises risk · Liquidity: current ratio 0.97, cash €316,718
NBB · annual accounts
raises risk · 5 establishment units
KBO · seat and establishments
raises risk · 1 financial year not filed after the legal deadline; latest accounts 29 days late
NBB · filings
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 12% of 6065 sector peers (2024).
NBB · sector comparison
Position among 6065 sector peers
Solvency
better than 12%
← weakest strongest →
raises risk · Annual accounts not filed
The financial year that closed on 31-12-2025 was due at the National Bank by 31-07-2026. Nothing is on record, 84 days later.
NBB · 4 filings
Position against the passed deadline
31-12-2025 year end31-07-2026 deadline23-10-2026 today
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 29-08-2025, 29 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 4 filings
Deviation from the deadline
2025
not filed
2024
29 days late
2023
37 days early
2022
29 days late
2021
16 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 4 accounts on average 9 days after the deadline; the sector median (NACE 46) for financial year 2024 is 3 days before the deadline, and 39% of those companies filed late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Capital & shares · Purpose ·…Permanent representatives: VAN HAMME Jean-Baptiste…
  2. Capital & shares · RestructuringAppointment: Marie Delacroix (statutory auditor)…
  3. Annual accounts filedfinancial year 2024 · full…

Key points

  • Caution: Among the weakest 13% on solvencysector median 41.9% · 6,065 companies 7.8% View
  • Caution: Accounts not fileddeadline was 31-07-2026 84 days late View
  • Controlled by INTERCONCEPTthe company in turn controls 1 companies 51% View
  • Restructuring with IC Storerestructuring on 29-12-2025 2025 View

By topic

Financials

Financial year
2024
Total assets
€5.2m
Profit
€5,386
Solvency
7.8%
Total assets▲ 25.3%
Net result
20212024
Go to Financials

Timeline

Events
9
Since
2022
  1. 31-12-2024Weakest financial year
  2. 24-06-2024Annual accounts filed
  3. 18-06-2024Registered office
Go to Timeline

Company details

Sites
5
Legal form
Private limited company
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Founded
23-03-2021
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
4
Financial year
From 1 July to 30 June
Annual meeting
Last Saturday of November at 15:00
Purpose
“L'achat et la vente, l'importation et l'exportation, en gros et en détail de produits…” (deed in French)
Go to Articles of association

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.